Despite significant scientific advancements made in substance use disorder research over the last century, the causes and consequences of drug use in later life remain poorly understood.
The intent of this funding opportunity announcement is to support innovative research that examines aspects
of marijuana and prescription opioid and benzodiazepine use in adults aged 50 and older.
This FOA encourages research that examines the determinants of these types of drug use and/or characterizes the resulting neurobiological alterations, associated behaviors, and public health consequences.
This initiative will focus on two distinct populations of older adults:
individuals with earlier onset of drug use who are now entering this stage of adult development or individuals who initiate drug use after the age of 5 0. Applications are encouraged to utilize broad methodologies ranging from basic science, clinical, and epidemiological approaches.
The insights gleaned from this initiative are critical to our understanding of the determinants of drug use in later life, as well as its consequences in the aging brain and on behavior.
This knowledge may have the potential to identify risk factors and to guide clinical practices in older populations.